You are here: Home » News-CM » Companies » News
Business Standard

Astrazeneca Pharma India receives Import and Market permission for Asthma drug

Capital Market 

From Drug Controller General of India

has received Import and Market permission in Form 45 (Marketing Authorization) from the Drug Controller General of for FDC of Budesonide 320 g +Formoterol Fumarate Dihydrate 9 g inhalation powder.

FDC of Budesonide 320 g + Formoterol Fumarate Dihydrate 9 g inhalation powder (Symbicort Turbuhaler 320/9 g) is a product of AstraZeneca global and is indicated in the regular treatment of Asthma where use of combination of inhaled regular corticosteroid & long acting agonist is appropriate and patients with moderate to severe COPD with frequent symptoms and a history of exacerbations

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, June 15 2017. 19:17 IST